Elevated International Normalized Ratio: A Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients
- PMID: 31236154
- PMCID: PMC6575138
- DOI: 10.14740/gr1179
Elevated International Normalized Ratio: A Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients
Abstract
Background: Portal vein thrombosis (PVT) is a complication that is commonly seen in patients with cirrhosis and an entity that leads to increased mortality in patients who undergo liver transplantation. This study aims to establish a link between an elevated international normalized ratio (INR) and the presence of PVT in a cohort of cirrhotic patients.
Methods: We retrospectively reviewed the electronic medical records of all patients diagnosed with cirrhosis in SBH Health System from 2013 to 2018. Among these patients we extracted baseline demographic data, laboratory results, co-morbidities and the presence of PVT.
Results: In total there were 268 patients who met our inclusion criteria. Twenty-two patients had PVT, while 246 patients did not. Of the 22 patients with PVT there was a statistically significant increase in INR when compared to patients without PVT. There was also a statistically significant increase in total bilirubin, alkaline phosphatase and platelet count.
Conclusions: Elevated INR levels are associated with the presence of PVT in patients with cirrhosis. These findings suggest a hypercoagulable state and could assist clinicians in risk-stratifying patients when making the decision to initiate anti-coagulation therapy.
Keywords: Anticoagulation; Cirrhosis; International normalized ratio; Portal vein thrombosis.
Conflict of interest statement
None of the authors have any financial conflict of interest.
Similar articles
-
Portal vein thrombosis in cirrhosis.J Clin Exp Hepatol. 2014 Dec;4(4):320-31. doi: 10.1016/j.jceh.2013.12.003. Epub 2013 Dec 31. J Clin Exp Hepatol. 2014. PMID: 25755579 Free PMC article. Review.
-
[Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):513-517. doi: 10.3760/cma.j.issn.1007-3418.2016.07.006. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27784429 Chinese.
-
Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis.Hepatol Res. 2009 Sep;39(9):882-7. doi: 10.1111/j.1872-034X.2009.00531.x. Epub 2009 Jul 8. Hepatol Res. 2009. PMID: 19619258
-
Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.J Vasc Interv Radiol. 2013 Dec;24(12):1808-16. doi: 10.1016/j.jvir.2013.08.018. Epub 2013 Oct 4. J Vasc Interv Radiol. 2013. PMID: 24099787
-
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.J Clin Transl Hepatol. 2020 Dec 28;8(4):432-444. doi: 10.14218/JCTH.2020.00067. Epub 2020 Nov 11. J Clin Transl Hepatol. 2020. PMID: 33447527 Free PMC article. Review.
Cited by
-
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.Life (Basel). 2020 Sep 4;10(9):177. doi: 10.3390/life10090177. Life (Basel). 2020. PMID: 32899804 Free PMC article.
References
-
- Mucino-Bermejo J, Carrillo-Esper R, Uribe M, Mendez-Sanchez N. Coagulation abnormalities in the cirrhotic patient. Ann Hepatol. 2013;12(5):713–724. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous